Member Info for Richob

https://bit.ly/3caeEyI

Alistair on Directors Talk yesterday.

Enjoy your cake. All the best.

I need some help please fellow AVCT holders. My wife has somehow managed to become a member on here and has finally managed how to do a post. She keeps looking at apartments in Tenerife so I need to buy more shares. Having been down the back of the settee and through all my trousers and jackets, I have been fortunate enough to find a website called "We buy any wife dot com" but need guidance with the answers to the questions .....
MAKE - I have assumed the answer to be UP
MODEL - I believe this is a straight yes or no response
AGE - This is a tricky one as apparently I have got this wrong in public before as it keeps changing
YEAR OF PURCHASE - I have this one correct
MILEAGE - Need to really think that one through
MANUAL/AUTOMATIC - Trickier than it sounds
INSURANCE - Not sure if this is about me or the wife
Any help and guidance would be appreciated. There must be a lot of people like me out there that will have looked at this site today I reckon.
Many thanks. Enjoy the weekend, enjoy your cake and all the best.

I posted something similar to this some time ago when the sp was lower and there weren't many of us on here. I am posting it again as a guide as to why I am invested.

I see Avacta as a cake that is being baked. There are five key ingredients:

Exclusive rights over Affimer technology

Two proprietary platforms - Affimer Biotherapeutics and preCision Chemotherapy

AVA 6000 clinical trials

Royalty deals that pay for R&D

Worldwide partnerships

The icing on the cake is the potential covid 19 five minute saliva test and the BAMS partnership can add the candles, both of which are in addition to the key ingredients.

Like all cakes they have to be mixed carefully, put in the oven at the right temperature and allowed to settle. Seems to me that we have an excellent baker and a team of high quality chefs on the job.

My thanks to Myles and Rich Ken for their quality inputs.

All the best. Enjoy your cake.

You could try refreshing the page if you don't have Level 2.
Trust this helps.

It seems that the placing has caused some people an issue.

If we look at the placing RNS for the rationale it says it is for:

1 The phase 1 clinical trial of AVA 6000

2 Advancing the Affimer pipeline with partners

3 Further commercial progress with partners

4 a pipeline of diagnostics for licensing

My conclusions, for what they are worth, are:

1 AVA 6000 is the key Avacta product

2 Looks like we have advanced the Affimer pipeline with partners, including a new partner, Cytiva

3 Commercial progress is key to business revenues

4 The licensing of diagnostics is key to future business revenues

I understand that some people just believe this is dilution but that depends on the size of the pot that there is to dilute going forward. I do not doubt that the pot size here will increase substantially and perhaps looking beyond one day is more appropriate than worrying about who has some allegedly cheap shares that anybody in the previous three weeks could have bought just as cheaply but didn't.

Not looking to argue the point as everybody needs to make their own decisions. Just seems sensible to base those decisions on facts.

All the best. Enjoy your cake.

Avact a cake
Avact a cake
Affimer man

Avact a cake
Avact a cake
As fast as you can

Produce it and test it
With partners worldwide
Bake it with preCision
And help turn the virus tide

Put in the best ingredient
6000 AVA
This very special company
Is going all the way

All the best. enjoy your cake.

I see we have had the now filtered "chase a buck daily" folk on here over the weekend.

What a joy and no surprises there then.

As they now run off to two new RNS companies today that leaves those that actually understand the true potential of this company able to buy more at a price perhaps not anticipated. Such is the AIM.

What cannot be altered are the ingredients we have in our company cake as highlighted yesterday.

Exclusive rights over Affimer technology

Two proprietary platforms in Affimer bio therapeutics and preCision chemotherapy

Worldwide partners

Royalty deals and paid for R&D

AVA 6000 clinical trials

All the best and enjoy your cake.

The Avacta cake as I see it has five ingredients.

Exclusive rights over Affimer technology

Two proprietary platforms (Affimer bio therapeutics and preCision chemotherapy)

Worldwide partners

Royalty deals with paid for R&D

The AVA 6000 clinical trials

There may be some icing on the cake with virus tests and/or vaccine involvement but not every cake needs icing.

All the best and enjoy your cake.

You may well be right but I thought that The Chief Medical Officer said it could take months and the end of May is only seven weeks away at most. Bearing in mind that the AVA6000 cancer treatment is the company's main aim this is an excellent side addition. No doubt we will find out better when the NYSE opens at 230 our time today. All the best.

Could be today Moonglow. All the best.

Either way, I am more interested in who is buying. I wouldn't be surprised if it is Zeus Capital or affiliated high net worth individuals. All the best.

DD, according to their accounts IP have been rationalising their holdings for the last year or so to create cash flow. I therefore don't see this as being about Avacta but being about IP. I could of course be wrong but that is how I read it. I will be more interested to know who is buying in here.

More raised than expected. Must be more interest than expected. All the best.

It will be interesting to see who has bought now that we know who has sold. All the best.

The news button here has an interesting phrase in it about institutional interest.
All the best.

Last year's accounts did advise of the need for fund raising (page 53) which said that should the group decide to accelerate the Affimer platform then further funding will be needed.
AVA6000 is the key development and that is what they are concentrating on if I have read the RNS correctly. Have added today and will continue to do so when I can. All the best.

That may well be the something that is going on 54.
We should find out soon enough.
All the best.

Agree that something is going on. Who knows what but we have had net buying of over 5 million shares in the last three days. All the best.

Humble apologies. I typed in news Avacta and that came up. In my excitement I did not look at the date. Note to self made. All the very best.

Aside of the incredible buying over the last two days, York Press are reporting a sale to DKSH in Japan.